ADP-ribosylation: from molecular mechanisms to human disease
AUTOR(ES)
Hoch, Nicolas C.
FONTE
Genet. Mol. Biol.
DATA DE PUBLICAÇÃO
13/12/2019
RESUMO
Abstract Post-translational modification of proteins by ADP-ribosylation, catalysed by poly (ADP-ribose) polymerases (PARPs) using NAD+ as a substrate, plays central roles in DNA damage signalling and repair, modulates a range of cellular signalling cascades and initiates programmed cell death by parthanatos. Here, we present mechanistic aspects of ADP-ribose modification, PARP activation and the cellular functions of ADP-ribose signalling, and discuss how this knowledge is uncovering therapeutic avenues for the treatment of increasingly prevalent human diseases such as cancer, ischaemic damage and neurodegeneration.
Documentos Relacionados
- Hormonal Stimulation of Eucaryotic Cell ADP-ribosylation: EFFECT OF THYROTROPIN ON THYROID CELLS
- Agonist-induced ADP-ribosylation of a cytosolic protein in human platelets.
- DNA strand breaks alter histone ADP-ribosylation.
- Nonenzymic ADP-ribosylation of specific mitochondrial polypeptides.
- Endogenous ADP-ribosylation of proteins in Mycobacterium smegmatis.